Efavirenz
- Product NDC
- 51407-382
- 11-digit product format
- 514070382
- Labeler code
- 51407
- Product ID
- 51407-382_f1d8c7f1-910f-94e8-e053-2a95a90af57f
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Efavirenz
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Golden State Medical Supply, Inc.
- Application
- ANDA204869
- Marketing category
- ANDA
- Marketing start
- 2018-03-12
- Marketing end
- 0000-00-00
- Substance
- EFAVIRENZ
- Active strength
- 600 mg/1
- Pharmacologic classes
- Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Non-Nucleoside Analog [EXT], Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2024-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 51407-382-30 | 51407038230 | 30 TABLET in 1 BOTTLE (51407-382-30) | 30 tablet | 2021-03-05 | 0000-00-00 | No | No | Current |